Revenue Breakdown
Composition ()
No data
Revenue Streams
Veru Inc (VERU) generates its revenue primarily from FC2, which accounts for 100.0% of total sales, equivalent to $6.66M. Understanding this concentration is critical for investors evaluating how VERU navigates market cycles within the Biotechnology & Medical Research industry.
Profitability & Margins
Evaluating the bottom line, Veru Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -60.25%, provide a clear picture of how effectively VERU converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, VERU competes directly with industry leaders such as NSRX and LITS. With a market capitalization of $42.05M, it holds a significant position in the sector. When comparing efficiency, VERU's gross margin of N/A stands against NSRX's N/A and LITS's N/A. Such benchmarking helps identify whether Veru Inc is trading at a premium or discount relative to its financial performance.
